Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases

R. ter Heine; R. Lange; O.B. Breukels; H.J. Bloemendal; R.G. Rummenie; A.M. Wakker; H. de Graaf; F.J. Beekman; M.M.L. van der Westerlaken; M.M. Malingre; J.P.M. Wielders; L. van den Berg; N.H. Hendrikse; J.M.H. de Klerk

doi:https://doi.org/10.1016/j.ijpharm.2014.01.034

Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases

R. ter Heine, R. Lange, O.B. Breukels, H.J. Bloemendal, R.G. Rummenie, A.M. Wakker, H. de Graaf, F.J. Beekman, M.M.L. van der Westerlaken, M.M. Malingre, J.P.M. Wielders, L. van den Berg, N.H. Hendrikse, J.M.H. de Klerk

Clinical pharmacology and pharmacy (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	317-324
Journal	International Journal of Pharmaceutics
Volume	465
Issue number	1-2
DOIs	https://doi.org/10.1016/j.ijpharm.2014.01.034
Publication status	Published - 2014

Access to Document

https://doi.org/10.1016/j.ijpharm.2014.01.034

Cite this

ter Heine, R., Lange, R., Breukels, O. B., Bloemendal, H. J., Rummenie, R. G., Wakker, A. M., de Graaf, H., Beekman, F. J., van der Westerlaken, M. M. L., Malingre, M. M., Wielders, J. P. M., van den Berg, L., Hendrikse, N. H., & de Klerk, J. M. H. (2014). Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases. International Journal of Pharmaceutics, 465(1-2), 317-324. https://doi.org/10.1016/j.ijpharm.2014.01.034

@article{87106e2333dc4e0ebb947677fce5c680,

title = "Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases",

author = "{ter Heine}, R. and R. Lange and O.B. Breukels and H.J. Bloemendal and R.G. Rummenie and A.M. Wakker and {de Graaf}, H. and F.J. Beekman and {van der Westerlaken}, M.M.L. and M.M. Malingre and J.P.M. Wielders and {van den Berg}, L. and N.H. Hendrikse and {de Klerk}, J.M.H.",

year = "2014",

doi = "https://doi.org/10.1016/j.ijpharm.2014.01.034",

language = "Undefined/Unknown",

volume = "465",

pages = "317--324",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

number = "1-2",

}

ter Heine, R, Lange, R, Breukels, OB, Bloemendal, HJ, Rummenie, RG, Wakker, AM, de Graaf, H, Beekman, FJ, van der Westerlaken, MML, Malingre, MM, Wielders, JPM, van den Berg, L, Hendrikse, NH & de Klerk, JMH 2014, 'Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases', International Journal of Pharmaceutics, vol. 465, no. 1-2, pp. 317-324. https://doi.org/10.1016/j.ijpharm.2014.01.034

TY - JOUR

T1 - Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases

AU - ter Heine, R.

AU - Lange, R.

AU - Breukels, O.B.

AU - Bloemendal, H.J.

AU - Rummenie, R.G.

AU - Wakker, A.M.

AU - de Graaf, H.

AU - Beekman, F.J.

AU - van der Westerlaken, M.M.L.

AU - Malingre, M.M.

AU - Wielders, J.P.M.

AU - van den Berg, L.

AU - Hendrikse, N.H.

AU - de Klerk, J.M.H.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1016/j.ijpharm.2014.01.034

DO - https://doi.org/10.1016/j.ijpharm.2014.01.034

M3 - Article

C2 - 24560635

SN - 0378-5173

VL - 465

SP - 317

EP - 324

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

IS - 1-2

ER -